BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 12886712)

  • 1. Leprosy in a Mexican immigrant.
    Baker B; Evans M; DeCastro F; Schosser R
    J Ky Med Assoc; 2003 Jul; 101(7):289-94. PubMed ID: 12886712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two microbiological relapses in a patient with lepromatous leprosy.
    Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
    Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leprosy: not always an easy diagnosis and often a management challenge.
    Manifold R; Marshman G
    Australas J Dermatol; 2009 Feb; 50(1):36-40. PubMed ID: 19178490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological resolution and bacterial clearance with pulse ROM therapy in borderline lepromatous leprosy.
    Suneetha S; Reddy R
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):53-4. PubMed ID: 11480321
    [No Abstract]   [Full Text] [Related]  

  • 5. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
    Armour KS; Scolyer RA; Barnetson RS
    Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generalized annular borderline tuberculoid leprosy and update in management of Hansen's disease.
    Young RJ; Gilson RT; Elston DM
    Cutis; 2000 Apr; 65(4):203-6. PubMed ID: 10795079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Borderline Lepromatous Leprosy with Type 1 (Reversal) Reactions in a Chinese Man.
    Fu X; Liu H; Zhang F
    Am J Trop Med Hyg; 2015 Aug; 93(2):207-209. PubMed ID: 26251526
    [No Abstract]   [Full Text] [Related]  

  • 8. Bigger may not always be better: giant borderline tuberculoid leprosy lesion.
    Ghorpade A
    Lepr Rev; 2005 Jun; 76(2):182-3. PubMed ID: 16038255
    [No Abstract]   [Full Text] [Related]  

  • 9. Relapses during long-term follow up with drug-susceptible M. leprae among multibacillary leprosy patients treated with multidrug therapy regimens; case reports.
    Thomas A; Hari L; Nagarajan M; Prabhakar R
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):391-4. PubMed ID: 7594922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case of Leprosy in Italy: A Multifaceted Disease Which Continues to Challenge Medical Doctors.
    Maritati M; Contini C
    J Immigr Minor Health; 2016 Apr; 18(2):490-3. PubMed ID: 26018958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leprosy acquired by inoculation from a knee injury.
    Brandsma JW; Yoder L; MacDonald M
    Lepr Rev; 2005 Jun; 76(2):175-9. PubMed ID: 16038253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and bacteriological progress of highly bacillated BL-LL patients discontinuing treatment after different periods of MDT.
    Katoch K; Natarajan M; Bagga A; Katoch VM
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):248-54. PubMed ID: 2071982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transepidermal elimination of Mycobacterium leprae in histoid leprosy: a case report suggesting possible participation of skin in leprosy transmission.
    Ghorpade AK
    Indian J Dermatol Venereol Leprol; 2011; 77(1):59-61. PubMed ID: 21220882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leprosy in a preschool child--a case report.
    Arora SK
    J Indian Med Assoc; 2007 Mar; 105(3):140. PubMed ID: 17824468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relapse rate in MB leprosy patients treated with 2-years of WHO-MDT is not low.
    Gelber RH; Balagon VF; Cellona RV
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):493-500. PubMed ID: 15755209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Leprosy: a rare imported disease].
    Gain M; Ghnaya H; Lepeytre F; Toledano C; Cabane J; Phong Tiev K
    Rev Med Interne; 2009 Dec; 30(12):1064-6. PubMed ID: 19836114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
    Chaudhury S; Hajra SK; Mukerjee A; Saha B; Majumdar V; Chattapadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leprosy pseudoimbricata: an unusual presentation of steroid-modified borderline lepromatous leprosy.
    Kumar S; Mehta H; Aggarwal D; Chatterjee D; Narang T; Dogra S
    Int J Dermatol; 2020 Apr; 59(4):e124-e125. PubMed ID: 31957882
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of leprosy.
    Kar HK; Gupta R
    Clin Dermatol; 2015; 33(1):55-65. PubMed ID: 25432811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.